Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Vaught

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of the Neurological Sciences|May 1, 1995
Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron diseaseD Hantaï, M Akaaboune, C Lagord, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Preclinical evaluation of McN-5707 as a potential antidepressantR P Shank, J F Gardocki, C R Schneider, et al.
Annals of the New York Academy of Sciences|August 27, 1993
The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disordersM E Lewis, J L Vaught, N T Neff, et al.
Journal of Medicinal Chemistry|May 9, 1998
Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivativesB E Maryanoff, M J Costanzo, S O Nortey, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1990
Antinociceptive action of McN-5195 in rodents: a structurally novel (indolizine) analgesic with a nonopioid mechanism of actionJ L Vaught, J R Carson, R J Carmosin, et al.
Neuroscience|January 9, 1999
Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularisM S Saporito, E R Brown, S Carswell, et al.
Brain Research|February 6, 1998
Insulin-like growth factor-I prevents development of a vincristine neuropathy in miceP C Contreras, J L Vaught, J A Gruner, et al.
Epilepsia|March 1, 1994
Topiramate: preclinical evaluation of structurally novel anticonvulsantR P Shank, J F Gardocki, J L Vaught, et al.
Journal of Medicinal Chemistry|May 23, 1997
Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agentsJ R Carson, R J Carmosin, P M Pitis, et al.
Neuroreport|August 3, 2000
CEP-1347 increases ChAT activity in culture and promotes cholinergic neurone survival following fimbria-fornix lesionS J Harper, M S Saporito, L Hewson, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of the Neurological Sciences|May 1, 1995
Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron diseaseD Hantaï, M Akaaboune, C Lagord, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Preclinical evaluation of McN-5707 as a potential antidepressantR P Shank, J F Gardocki, C R Schneider, et al.
Annals of the New York Academy of Sciences|August 27, 1993
The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disordersM E Lewis, J L Vaught, N T Neff, et al.
Journal of Medicinal Chemistry|May 9, 1998
Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivativesB E Maryanoff, M J Costanzo, S O Nortey, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1990
Antinociceptive action of McN-5195 in rodents: a structurally novel (indolizine) analgesic with a nonopioid mechanism of actionJ L Vaught, J R Carson, R J Carmosin, et al.
Neuroscience|January 9, 1999
Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularisM S Saporito, E R Brown, S Carswell, et al.
Brain Research|February 6, 1998
Insulin-like growth factor-I prevents development of a vincristine neuropathy in miceP C Contreras, J L Vaught, J A Gruner, et al.
Epilepsia|March 1, 1994
Topiramate: preclinical evaluation of structurally novel anticonvulsantR P Shank, J F Gardocki, J L Vaught, et al.
Journal of Medicinal Chemistry|May 23, 1997
Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agentsJ R Carson, R J Carmosin, P M Pitis, et al.
Neuroreport|August 3, 2000
CEP-1347 increases ChAT activity in culture and promotes cholinergic neurone survival following fimbria-fornix lesionS J Harper, M S Saporito, L Hewson, et al.
Pageof 8